Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator.

Antimicrobial Agents and Chemotherapy
Aki Okazaki, Matthew B Avison

Abstract

A divergently oriented ampR has been located upstream of blaL2 in Stenotrophomonas maltophilia. AmpR is necessary for L1 and L2 beta-lactamase induction in response to beta-lactam challenge, and activation of AmpR is sufficient to induce L1 and L2 production. L1 induction requires more activation of AmpR than does L2 induction.

References

Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Feb 19, 2000·Antimicrobial Agents and Chemotherapy·A KugaM Inoue
Jun 23, 2001·The Journal of Antimicrobial Chemotherapy·J M Andrews
Jan 30, 2002·The Journal of Antimicrobial Chemotherapy·Matthew B AvisonPeter M Bennett
May 15, 2003·The Journal of Antimicrobial Chemotherapy·Pannika NiumsupMatthew B Avison
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Shu-Fen WengYi-Hsiung Tseng
Nov 8, 2006·Antimicrobial Agents and Chemotherapy·Aki Okazaki, Matthew B Avison

❮ Previous
Next ❯

Citations

Apr 17, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y-C ChangT-C Chung
Jul 2, 2011·The Journal of Antimicrobial Chemotherapy·Cheng-Wen LinTsuey-Ching Yang
Nov 14, 2012·Antimicrobial Agents and Chemotherapy·Virginia C GouldMatthew B Avison
Apr 14, 2010·Antimicrobial Agents and Chemotherapy·Yi-Wei HuangTsuey-Ching Yang
May 6, 2009·Antimicrobial Agents and Chemotherapy·Tsuey-Ching YangYu-Tzu Lin
Jan 19, 2012·Antimicrobial Agents and Chemotherapy·Yi-Wei HuangTsuey-Ching Yang
Feb 1, 2012·Antimicrobial Agents and Chemotherapy·Lisandro J González, Alejandro J Vila
Jan 11, 2012·Clinical Microbiology Reviews·Joanna S Brooke
Aug 8, 2009·Future Microbiology·Maria B SanchezJose L Martinez
Jun 5, 2012·Applied Microbiology and Biotechnology·Laurence Van OudenhoveBart Devreese
Apr 21, 2011·Expert Review of Anti-infective Therapy·Iain J AbbottLeon J Worth
Apr 28, 2009·The Lancet Infectious Diseases·W John LooneyKathrin Mühlemann
Dec 17, 2008·Research in Microbiology·Cheng-Wen LinTsuey-Ching Yang
Jan 22, 2013·Reproduction in Domestic Animals = Zuchthygiene·C KilburnR D Murray
Jul 30, 2014·Pathogens and Disease·Deepak BalasubramanianKalai Mathee
May 31, 2018·Antimicrobial Agents and Chemotherapy·Karina Calvopiña, Matthew B Avison
Aug 20, 2014·Antimicrobial Agents and Chemotherapy·Jianhua YinHaichun Gao
Aug 5, 2017·Journal of Medical Microbiology·Akira FukudaYutaka Tamura
Feb 14, 2020·Expert Review of Anti-infective Therapy·Teresa Gil-GilPaula Blanco
Mar 21, 2020·Microbiology Resource Announcements·Shiori YamamotoHiroshi Asakura
Dec 24, 2018·Frontiers in Microbiology·Fabio GentiliniRenato Giulio Zanoni
Aug 28, 2020·Frontiers in Cellular and Infection Microbiology·Zhongliang DuanChunmei Ying

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.